Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2024
Institutional positions in Nuvalent, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 193
- +23 vs. Q2 2024
- Shares held
- 70.1M
- +7.57M (+12.1%) vs. Q2 2024
- Total value
- $7.17B
- +$2.43B (+51.1%) vs. Q2 2024
- New holders
- 47
- 73 more added
- Sold out
- 24
- 54 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NUVL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 292 | $9.29B |
| Q1 2026 | 265 | $8.30B |
| Q4 2025 | 237 | $8.04B |
| Q3 2025 | 196 | $6.26B |
| Q2 2025 | 209 | $5.49B |
| Q1 2025 | 205 | $5.11B |
| Q4 2024 | 217 | $5.53B |
| Q3 2024 | 193 | $7.17B |
| Q2 2024 | 172 | $4.98B |
| Q1 2024 | 180 | $4.78B |
| Q4 2023 | 155 | $4.68B |
| Q3 2023 | 116 | $2.57B |
| Q2 2023 | 111 | $2.33B |
| Q1 2023 | 89 | $1.41B |
| Q4 2022 | 96 | $1.58B |
| Q3 2022 | 60 | $879.5M |
| Q2 2022 | 55 | $622.5M |
| Q1 2022 | 55 | $629.0M |
| Q4 2021 | 49 | $813.1M |
| Q3 2021 | 47 | $941.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Nuvalent, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −12,132−100.0% | Sold out |
| Bank of Hawaii | 0 | $0 | 0.00% | −6,995−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −6,110−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −5,700−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −3,405−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −3,266−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −2,954−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −2,701−100.0% | Sold out |
| Mount Yale Investment Advisors, LLC | 0 | $0 | 0.00% | −2,655−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −2,294−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −2,212−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −574−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −368−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Oliver Lagore Vanvalin Investment Group | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Lynx Investment Advisory | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Institutional & Family Asset Management, LLC | – | – | – | – | Not filed |